Table 1 Patient demographics. *p < 0.05, **p < 0.01, and ***p < 0.001 compared to COVID-19 negative patients. ^ p < 0.05, ^^ p < 0.01, and ^^^ p < 0.001 between hospitalized and non-hospitalized COVID-19 patients.
From: Incidence and risk factors of new-onset hypertension up to 3 years post SARS-CoV-2 infection
Demographics | COVID-positive hospitalized (5,550) | COVID-positive non-hospitalized (N = 37,350) | COVID-negative (172,660) |
|---|---|---|---|
Age | 50.4 ± 23.7***^^^ | 36.5 ± 22.4*** | 35.9 ± 23.8 |
Male | 3000 (54%)***^^^ | 15,680 (42%)*** | 72,810 (45%) |
White race | 3490 (63%)***^^^ | 19,510 (52%)*** | 96,640 (56%) |
Black race | 390 (7%)^^^ | 2040 (5%)*** | 11,130 (6%) |
Asian race | 160 (3%) | 1280 (3%)^ | 5890 (3%) |
Unknown race | 1500 (27%)*** | 14,380 (39%)***^^^ | 59,040 (34%) |
Non-hispanic | 3720 (67%)***^^^ | 22,200 (59%)*** | 111,260 (64%) |
Hispanic | 1130 (20%)***^^^ | 6080 (16%)*** | 30,250 (18%) |
Unknown ethnicity | 700 (13%)*** | 9080 (24%)***^^^ | 31,800 (18%) |
Comorbidities | |||
CAD | 300 (5%)***^^^ | 990 (3%)*** | 3190 (2%) |
CHF | 190 (3%)***^^^ | 350 (1%)** | 1300 (1%) |
CKD | 150 (3%)***^^^ | 360 (1%)*** | 1100 (1%) |
Diabetes | 340 (6%)***^^^ | 1520 (4%)*** | 4660 (2%) |
COPD | 200 (4%)***^^^ | 460 (1%)** | 1780 (1%) |
Asthma | 450 (8%) | 4510 (12%)***^^^ | 14,320 (9%) |
Obesity | 550 (10%)*** | 4350 (12%)***^^^ | 13,510 (8%) |
Tobacco use | 140 (3%)***^^ | 720 (2%)*** | 2700 (2%) |
